Short Interest in ZIVO Bioscience, Inc. (NASDAQ:ZIVOW) Grows By 27.1%

ZIVO Bioscience, Inc. (NASDAQ:ZIVOWGet Rating) was the target of a significant increase in short interest during the month of December. As of December 30th, there was short interest totalling 6,100 shares, an increase of 27.1% from the December 15th total of 4,800 shares. Based on an average trading volume of 5,600 shares, the short-interest ratio is presently 1.1 days.

ZIVO Bioscience Stock Performance

Shares of ZIVOW opened at $0.88 on Friday. The company’s 50 day simple moving average is $0.69 and its 200-day simple moving average is $0.76. ZIVO Bioscience has a 12-month low of $0.23 and a 12-month high of $1.52.

Hedge Funds Weigh In On ZIVO Bioscience

A hedge fund recently raised its stake in ZIVO Bioscience stock. Warberg Asset Management LLC lifted its holdings in shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOWGet Rating) by 442.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 84,654 shares of the company’s stock after acquiring an additional 69,034 shares during the period. Warberg Asset Management LLC’s holdings in ZIVO Bioscience were worth $51,000 at the end of the most recent reporting period.

About ZIVO Bioscience

(Get Rating)

ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.

Further Reading

Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.